This module allows you to analyze existing cross correlation between Digirad Corporation and Edwards Lifesciences Corporation. You can compare the effects of market volatilities on Digirad and Edwards Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Digirad with a short position of Edwards Lifesciences. See also your portfolio center
. Please also check ongoing floating volatility patterns of Digirad
and Edwards Lifesciences
Digirad Corp. vs Edwards Lifesciences Corp.
Given the investment horizon of 30 days, Digirad Corporation is expected to generate 4.06 times more return on investment than Edwards Lifesciences. However, Digirad is 4.06 times more volatile than Edwards Lifesciences Corporation. It trades about 0.19 of its potential returns per unit of risk. Edwards Lifesciences Corporation is currently generating about 0.53 per unit of risk. If you would invest 230 in Digirad Corporation on December 24, 2017 and sell it today you would earn a total of 35 from holding Digirad Corporation or generate 15.22% return on investment over 30 days.
|Time Period||1 Month [change]|
Very weak diversification
Overlapping area represents the amount of risk that can be diversified away by holding Digirad Corp. and Edwards Lifesciences Corp. in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Edwards Lifesciences and Digirad is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Digirad Corporation are associated (or correlated) with Edwards Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edwards Lifesciences has no effect on the direction of Digirad i.e. Digirad and Edwards Lifesciences go up and down completely randomly.
Compared to the overall equity markets, risk-adjusted returns on investments in Digirad Corporation are ranked lower than 12 (%) of all global equities and portfolios over the last 30 days.
Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corporation are ranked lower than 35 (%) of all global equities and portfolios over the last 30 days.